Compounds > arginine

arginine and paromomycin

arginine has been researched along with paromomycin in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (66.67)29.6817
2010's2 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Detering, C; Varani, G1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Hinnebusch, AG; Sattlegger, E1
Borkow, G; Kalinkovich, A; Lapidot, A; Lara, HH; Vijayabaskar, V1
James, TL; Lapidot, A; Litovchick, A; Vijayabaskar, V; Yu, J1

Reviews

1 review(s) available for arginine and paromomycin

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

5 other study(ies) available for arginine and paromomycin

ArticleYear
Validation of automated docking programs for docking and database screening against RNA drug targets.
    Journal of medicinal chemistry, 2004, Aug-12, Volume: 47, Issue:17

    Topics: Algorithms; Aminoglycosides; Anti-Bacterial Agents; Binding Sites; Databases, Factual; Ligands; Models, Molecular; Nucleic Acid Conformation; Quantitative Structure-Activity Relationship; RNA; RNA, Ribosomal; Software

2004
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Separate domains in GCN1 for binding protein kinase GCN2 and ribosomes are required for GCN2 activation in amino acid-starved cells.
    The EMBO journal, 2000, Dec-01, Volume: 19, Issue:23

    Topics: Alanine; Alleles; Anti-Bacterial Agents; Arginine; Binding Sites; DNA-Binding Proteins; Electrophoresis, Polyacrylamide Gel; Escherichia coli; Fungal Proteins; Genes, Dominant; Glutathione Transferase; Models, Biological; Paromomycin; Peptide Elongation Factors; Peptide Initiation Factors; Phenotype; Phosphorylation; Polyribosomes; Prokaryotic Initiation Factor-2; Protein Binding; Protein Biosynthesis; Protein Kinases; Protein Serine-Threonine Kinases; Protein Structure, Tertiary; Recombinant Fusion Proteins; Ribosomes; RNA, Transfer; Saccharomyces cerevisiae Proteins; Yeasts

2000
Structure-activity relationship of neomycin, paromomycin, and neamine-arginine conjugates, targeting HIV-1 gp120-CXCR4 binding step.
    Antiviral research, 2003, Volume: 60, Issue:3

    Topics: Anti-HIV Agents; Antibodies, Monoclonal; Arginine; Cell Line; Cells, Cultured; Chemokine CCL5; Chemokine CXCL12; Chemokines, CXC; Drug Resistance, Viral; Framycetin; HIV Envelope Protein gp120; HIV-1; Humans; Leukocytes, Mononuclear; Neomycin; Paromomycin; Receptors, CXCR4; Structure-Activity Relationship; Virus Replication

2003
Structure-activity relationships of aminoglycoside-arginine conjugates that bind HIV-1 RNAs as determined by fluorescence and NMR spectroscopy.
    FEBS letters, 2004, Nov-19, Volume: 577, Issue:3

    Topics: Aminoglycosides; Anti-Bacterial Agents; Arginine; Binding Sites; Fluorescence Polarization; HIV-1; Molecular Structure; Neomycin; Nuclear Magnetic Resonance, Biomolecular; Paromomycin; RNA, Viral; Structure-Activity Relationship

2004